Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €837.00 | €957.22 | 14.363% |
| Stoke Therapeutics Inc | 14 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €457.25 | €543.72 | 18.911% |
| Bayer AG | 15 | 1 | 0 | 0 | €27.60 | €50.00 | 81.159% |
| G1 Therapeutics | 13 | 1 | 1 | 0 | €3.47 | €10.05 | 190.075% |
| Edap Tms S.A. ADR | 3 | 1 | 1 | 0 | €6.70 | €14.79 | 120.776% |
| Staar Surgical Co. | 11 | 1 | 4 | 0 | €44.22 | €49.02 | 10.850% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €61.00 | €109.59 | 79.648% |
| Cryolife Inc. | 1 | 1 | 0 | 0 | €19.56 | €10.00 | -48.875% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.00 | €73.92 | 7.130% |
| Adverum Biotechnologies Inc. | 5 | 1 | 1 | 0 | €1.38 | €3.72 | 169.623% |
| AnaptysBio Inc | 7 | 1 | 2 | 0 | €19.90 | €45.21 | 127.186% |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €118.50 | €130.44 | 10.074% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.65 | - | - |
| Insmed Inc. | 13 | 1 | 3 | 1 | €23.20 | €44.01 | 89.684% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €68.12 | €79.30 | 16.413% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.20 | €51.20 | 49.700% |
| Molina Healthcare | 11 | 1 | 1 | 0 | €320.70 | €359.93 | 12.234% |
| Gilead Sciences Inc | 11 | 1 | 4 | 0 | €61.51 | €88.73 | 44.253% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €76.22 | €85.68 | 12.417% |
| Addus Homecare Corp. | 12 | 1 | 0 | 1 | €87.00 | €98.14 | 12.807% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €121.40 | €124.93 | 2.907% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.33 | €4.57 | 96.469% |